US Broker Ratings

Mereo BioPharma Group plc (MREO) Stock Analysis: A Potential 162% Upside in the Biotech Sector

Mereo BioPharma Group plc (NASDAQ: MREO), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust therapeutic pipeline and ambitious growth prospects. Headquartered in..

Spok Holdings, Inc. (SPOK) Stock Analysis: High Dividend Yield and Notable Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK), a prominent player in the healthcare communication solutions sector, offers a compelling investment opportunity with its high dividend yield and significant potential upside. With a..

Olema Pharmaceuticals (OLMA) Stock Analysis: A Biotech with an Impressive 502.79% Potential Upside

For investors seeking opportunities in the dynamic biotech industry, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) presents a compelling case. With a market capitalization of $280.53 million, this San Francisco-based company is..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 206% Potential Upside in the Medical Devices Sector

For investors eyeing opportunities in the healthcare sector, Senseonics Holdings, Inc. (NYSEAMERICAN: SENS) presents an intriguing prospect, especially given its standout potential upside of 206.69%. This commercial-stage medical technology company..

Abeona Therapeutics Inc. (ABEO) Investor Outlook: Exploring a Potential 232% Upside

Abeona Therapeutics Inc. (NASDAQ: ABEO) stands out in the biotechnology sector with its intriguing blend of innovative therapies and significant market potential. As a clinical-stage biopharmaceutical company, Abeona is making..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A Biotechnology Bet with 72% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology firm specializing in DNA-directed RNA interference-based therapeutics, is currently capturing investor attention, thanks to its robust analyst ratings and significant potential upside...

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a Promising 160.66% Potential Upside

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is making waves in the biotechnology sector, captivating investor attention with its cutting-edge approach to cancer treatment and potential for significant stock price appreciation. With..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 169% Potential Upside in the Biotech Arena

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the biotechnology sector, is capturing the attention of investors with its compelling growth narrative and significant market potential. The clinical-stage biopharmaceutical..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A Stable Contender in the Healthcare Sector with Modest Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) has been a reliable name in the healthcare services industry, providing indispensable management and operational services to nursing homes, retirement complexes, rehabilitation centers, and..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling a 197% Potential Upside in the Biotech Sector

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based clinical-stage biotechnology company, is capturing attention in the healthcare sector with an impressive potential upside of 197.59%. As a pioneering entity in..

NeoGenomics, Inc. (NEO) Stock Analysis: Unveiling a Potential 51.82% Upside for Investors

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, operates at the forefront of cancer diagnostics and research. With a market capitalization of $953.63 million, the company’s innovative..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring a 140% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) stands at an intriguing crossroads in the biotechnology sector, capturing the attention of investors with its promising pipeline targeting rare diseases. As the company ventures..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: Evaluating a 24.90% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling opportunity for investors who are keen on the healthcare sector, particularly in the realm of non-opioid pain management. With a market capitalization..

Novavax, Inc. (NVAX) Stock Analysis: A Potential 108.63% Upside in the Biotech Sector

Novavax, Inc. (NASDAQ: NVAX) is a prominent player in the biotechnology industry, operating out of Gaithersburg, Maryland. The company is noted for its innovative approach to vaccine development, particularly its..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unpacking a 26% Potential Upside with Strong Revenue Growth

For investors eyeing opportunities in the healthcare sector, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling prospect. This biopharmaceutical company, headquartered in Baudette, Minnesota, is making waves with its robust..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 100% Potential Upside in the Biotechnology Arena

MiMedx Group, Inc. (MDXG) is carving a noteworthy niche in the biotechnology sector with its innovative approach to healthcare solutions, specifically through its development and distribution of placental tissue allografts...

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling a 36% Upside Potential for Investors

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a key player in the healthcare sector with a focus on medical devices, is capturing investor attention with its impressive growth prospects. Headquartered in..

Agios Pharmaceuticals (AGIO) Stock Analysis: Exploring a 44.66% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is gaining attention from investors due to its promising developments in cellular metabolism medicines. With a market capitalization..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 63% Upside Potential in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out in the healthcare sector, particularly within the medical devices industry, with its robust portfolio of diabetes management solutions. Headquartered in San Diego,..

agilon health, inc. (AGL) Stock Analysis: Exploring the 95% Potential Upside

For investors eyeing opportunities in the healthcare sector, agilon health, inc. (NYSE: AGL) presents a compelling case, especially with a potential upside of 95.12% as indicated by current analyst ratings...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds